Boston, MA, 03/12/2014 – With the option of cheaper finance knocking the door, Radnet Inc. (NASDAQ:RDNT) has decided to re-finance its senior notes which were due in 2018 and are worth $200 million. The company has started looking for different option in this refinancing. It has also decided to expand into 3D mammography, which is far more beneficial than the 2D mammography, which was previously used by the company.
Refinancing of senior notes
Radnet is one of the fastest growing companies in the market, which has decided to replace its high cost debts with the lower cost ones. This is possible for the company because of the prevailing interest rates which are quite low as compared to previous ones. This decision will surely have a long term impact on the company’s profitability.
Radnet has revealed its plan to purchase senior notes due in 2018 worth $200 million. The company has estimated $30 per Note as a consent payment. March 20 will be the last day of this offer and any tender which drops after this date and before April 3, 2014 will be paid the amount without the consent payment of $30 per Note.
Replacements for 2D Mammograms
The currently used mammograms by Radnet are about to be replaced with the 3D mammograms. These new technology mammograms are far more advantageous than the previous ones. They provide this feature of increased scan speed and reduced radiation exposure.
Radnet Inc. (NASDAQ:RDNT) says that these mammograms are much more efficient in detecting cancer in patients, especially in women with dense breast tissues. With the technology supporting 3D mammograms, it is less likely to provide you with a false positive finding of cancer and is also able to reduce the cost of different tests. These mammograms are able to detect the tiniest tumors and reflect it on a high resolution computer.